Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Roche reports positive studies of MabThera given by subcutaneous injection
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Boehringer Ingelheim and Apexigen sign manufacturing agreement
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Novo Nordisk to create the world's first all-diabetes professional cycling team
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](/images/stories/logo/novonordisk_b.gif)
GSK welcomes the publication of the 2012 Access to Medicines Index
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
More Pharma News ...
- Sanofi ranks third on the Access to Medicine Foundation's 2012 ATM Index
- Novartis highlights key data in patients with hematologic diseases and breast cancer
- Novartis receives FDA approval for Flucelvax®
- Shire and Boston Children's Hospital enter into broad research collaboration
- Results from the positive phase III AVAglio study
- Bayer's "Perspective on Innovation 2012"
- Sanofi and T1D Exchange to launch worldwide study